Article

Preliminary evaluation of the safety and efficacy of oral human antimicrobial peptide LL-37 in the treatment of patients of COVID-19, a small-scale, single-arm, exploratory safety study

2020-05-15

Abstract excerpt

<h4>Background& Aims</h4> The Coronavirus Disease 2019 (COVID-19) has become a global epidemic and has caused a lasting and huge loss of life security, economic development and social stability in more than 180 countries around the world. Unfortunately, there is still no specific treatment for COVID-19 till now, therefore, at this point, all potential therapies need to be critically considered. LL-37 is one of the...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 09130581-0849-534b-8685-7a8cd75db15c
DOI: 10.1101/2020.05.11.20064584

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Preliminary evaluation of the safety and efficacy of oral human antimicrobial peptide LL-37 in the treatment of patients of COVID-19, a small-scale, single-arm, exploratory safety studyDOI 10.1101/2020.05.11.20064584Read

An in silico scientific basis for LL ‐37 as a therapeutic for Covid‐19Semantic proximity Read

Hybrid Derivative of Cathelicidin and Human Beta Defensin-2 Against Gram-Positive Bacteria: A Novel Approach for the Treatment of Bacterial KeratitisSemantic proximity Read

Targeted Modification of the Antimicrobial Peptide DGL13K Reveals a Naturally Optimized Sequence for Topical ApplicationsSemantic proximity Read

Harnessing the Power of GFP Fusion in E. coli for Well-Optimized Expression and Enhanced Characterization of Human Hepcidin-25Semantic proximity Read

The spectrum of antibacterial activity of human defensins and cathelicidin against gram-positive and gram-negative bacterial strains isolated from hospitalized patientsSemantic proximity Read

A bioengineered probiotic for the oral delivery of a peptide Kv1.3 channel blocker to treat rheumatoid arthritisSemantic proximity Read

OmpA Binding Mediates the Effect of Antimicrobial Peptide LL-37 on Acinetobacter baumannii.Semantic proximity Read

Antimicrobial Activities of LL-37 Fragment Mutant-Poly (Lactic-Co-Glycolic) Acid Conjugate against Staphylococcus aureus, Escherichia coli, and Candida albicans.Semantic proximity Read

Milk Derived Antimicrobial Bioactive Peptides: A ReviewSemantic proximity Read

Efficacy of <i>Lactococcus lactis</i> strain plasma (LC-Plasma) in easing symptoms in patients with mild coronavirus disease 2019 (COVID-19): protocol for an exploratory, multicenter, double-blinded, randomized controlled trial (PLATEAU study)Semantic proximity Read

Separability of antibacterial and membranolytic activity in the human host defense peptide LL-37Semantic proximity Read

Decoding the functional roles of cationic side chains of the major antimicrobial region of human cathelicidin LL-37.Semantic proximity Read